Patent · US Active

Agents that modulate immune cell activation and methods of use thereof

US11359020B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignees

DANA-FARBER CANCER INSTITUTE, INC. · US
President and Fellows of Harvard College · US
Children's Medical Center Corporation · US

Inventors

Gordon J. Freeman · Brookline, US
Arlene H. Sharpe · Brookline, US
Yanping Xiao · Brookline, US
Loise M. Francisco · Belmont, US
Rosemarie Dekruyff · Newton, US
Dale T. Umetsu · Stanford, US

Key dates

Filing date	Sep 16, 2019
Grant date	Jun 14, 2022
Priority date	—
Expiry date	Aug 11, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.